Searched for
VITILIGO TREATMENT
World Vitiligo Day 2023: Raising awareness and promoting understanding of a rare skin conditionAccording to the National Institutes of Health (NIH), the prevalence of vitiligo in India ranges from 0.25% to 4% among dermatology outpati...
New skin cream for vitiligo treatment causes controversyThe skin cream has been named as "miracle cream."
Celine Dion diagnosed with 'rare, 1 in a million' Stiff Person Syndrome; singer says spasms hurting her vocal chordsThe 54-year-old singer has called off her European tour.
Namma Homeopathy clinic gains popularity in Maharashtra and Karnataka due to its effective treatmentHomeopathy is a proven and effective method of medicine to fight diseases and Namma Homeopathy clinic have shown effective treatment all ov...
DRDO herbal drug Lukoskin finding huge takers, says AIMIL HealthcareTill now, more than one lakh patients suffering from the skin condition, also known as leucoderma, have been treated with Lukoskin, with an...
India's science and tech centres double up as startup ideation hubsIndia’s science and technology institutions have become fertile grounds for startups, having built ecosystems that will help convert resear...
Love that face cream? Here's the damage it may be causing and what you can do about itIt’s time to stop the abuse of steroids in skincare. Use creams only after consulting a dermatologist.
Arthritis drug may treat eczemaStandard treatments, such as steroid creams and oral medicines, commonly fail to relieve symptoms in patients with moderate to severe eczem...
Ten stocks in focus in Friday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
Dr Reddy's Laboratories in partnership with Issar Pharmaceuticals launches skin disorder lotion Melgain in IndiaDrug firm Dr Reddy's Laboratories today launched Melgain lotion used for treatment of vitiligo, a skin disorder in India.
- Biocon to launch psoriasis drug novel biologic in July
The company had received marketing authorisation for Itolizumab from the Drugs Controller General of India (DCGI) in January, 2013.
Biocon gets approval to market anti-psoriasis drug Itolizumab by DCGIThe company said the approval paved the way for the launch of the product, under the brand name Alzumab.
Biocon gets DCGI approval to market anti-psoriasis drug, Itolizumab"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...
- Wockhardt in licensing pact with UK firm for acne drug
Wockhardt Ltd has signed an in-licensing agreement with Crawford Healthcare, UK to market Zindaclin, a patented topical application for acn...
- Wockhardt signs in-licensing agreement with UK's LSI
Wockhardt has signed an in-licensing agreement with LSI, a UK-based company specialising in dermatology, to market Vitix, a patented produc...
- Wockhardt signs in-licensing agreement with UK
Drug maker Wockhardt Ltd has signed an in-licensing agreement with UK-based LSI to market Vitix, a drug used for treating pigmentation diso...